Net selling: insiders sold $957K and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $6K to $139K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Millennium
$78.5M
bought
D.E. Shaw
$68.4M
added
Sells/Trims (1)
Two Sigma
$94.0M
trimmed
No tracked top-trader positions in STE as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Financial period
Q1 FY2027
Earnings per share
$2.49 expected
Revenue
$1.50B expected
Estimates as of Oct 24, 2026
EPS expected
$2.66 to $2.70
Revenue expected
6 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $2.59 / $2.49Yahoo Finance | +3.89% beat | $1.49B $1.50B expected | -0.16% miss |
| Mar 31, 2026 | May 11, 2026 | $2.83 / $2.85Yahoo Finance | -0.65% in line | $1.59B No estimate | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $2.53 / $2.53Yahoo Finance | -0.10% in line | $1.50B No estimate | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $2.47 / $2.35Yahoo Finance | +5.05% beat | $1.46B No estimate | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $2.34 / $2.26Alpha Vantage | +3.54% beat | $1.39B No estimate | Unavailable |
| Mar 31, 2025 | May 14, 2025 | $2.74 / $2.60Alpha Vantage | +5.38% beat | $1.48B No estimate | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $2.32 / $2.32Alpha Vantage | +0.00% in line | $1.37B No estimate | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | $2.14 / $2.13Alpha Vantage | +0.47% in line | $1.33B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.46B | $1.50B | $1.59B | $1.49B |
| Cost of what it sold | $814.4M | $840.6M | $891.3M | $808.5M |
| Gross profit | $645.9M | $655.5M | $697.1M | $684.2M |
| What it spent | ||||
| Research and development | $28.2M | $29.5M | $28.8M | $28.6M |
| Sales and admin | $349.7M | $352.3M | $351.8M | $369.7M |
| Total operating expenses | $380.1M | $382.3M | $380.6M | $398.4M |
| What was left | ||||
| Operating profit | $268.0M | $271.0M | $316.8M | $285.8M |
| Interest on debt | $14.9M | $14.8M | $15.1M | $15.8M |
| Profit before tax | $253.1M | $257.8M | $304.5M | $273.5M |
| Tax | $60.6M | $63.5M | $84.2M | $72.5M |
| Net profit | $191.9M | $192.8M | $220.3M | $200.1M |
| EBITDA | $389.7M | $391.2M | $443.0M | $406.1M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Steris to acquire Pennsylvania surgical products maker for $2.1B — plus 3 more M&A deals to know
BullishOct 23STERIS plc (Ireland) Estimates – BOATS:STE
NeutralOct 23ResMed Inc. (RMD) Stock forecasts
NeutralOct 23Steris PLC stock outperforms competitors on strong trading day
BullishOct 22Steris PLC stock underperforms Wednesday when compared to competitors
BearishOct 21Sonoco Products Company (NYSE:SON) to Issue Quarterly Dividend of $0.54
NeutralOct 21STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
NeutralOct 21Steris plc to host Q2FY27 earnings conference call on Nov 5
NeutralOct 21